Anaphylaxis in Opticrom - how severe and when it was recovered? (a real world drug study)
Summary:
We study how severe was Anaphylaxis, when it was recovered, drug effectiveness, race, and more among people who take Opticrom (cromolyn sodium). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.
What is Opticrom?
Opticrom has active ingredients of cromolyn sodium. eHealthMe is studying from 95 Opticrom users. Check the latest studies of Opticrom.
What is Anaphylaxis?
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death) is found to be associated with 1,935 drugs and 2,859 conditions by eHealthMe. Check the latest studies of Anaphylaxis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
1 person who has Anaphylaxis while taking Opticrom was studied.

Severity of Anaphylaxis *:
- least: 0.0 %
- moderate: 0.0 %
- severe: 100 %
- most severe: 0.0 %
When people recovered from Anaphylaxis *:
- while on drug: 0.0 %
- after off the drug: 100 %
- not yet: 0.0 %
Effectiveness of Opticrom *:
- not at all: 0.0 %
- somewhat: 0.0 %
- moderate: 100 %
- high: 0.0 %
- very high: 0.0 %
Race of the people *:
- African American, Non-Hispanic: 0.0 %
- American Indian/Alaska Native: 0.0 %
- Asian: 0.0 %
- Hispanic: 0.0 %
- Native Hawaiians/Pacific Islanders: 0.0 %
- Two or more races: 0.0 %
- White, Non-Hispanic: 100 %
Time on Opticrom *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 100 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people when taking Opticrom *:
- female: 100 %
- male: 0.0 %
Age of people when taking Opticrom *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Conditions people have *:
- Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 100.00%
- Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 100.00%
- Allergies: 1 person, 100.00%
Other drugs people take besides Opticrom *:
- Zyrtec: 1 person, 100.00%
- Xolair: 1 person, 100.00%
- Vitamin D: 1 person, 100.00%
- Famotidine: 1 person, 100.00%
- Calcium: 1 person, 100.00%
Other side effects people have besides Anaphylaxis *:
- Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 100.00%
- Hives: 1 person, 100.00%
- Gallstones (stone formation by bile component): 1 person, 100.00%
- Abdominal Pain: 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Opticrom and have Anaphylaxis?
Check whether Anaphylaxis is associated with a drug or a conditionHow to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
How the study uses the data?
The study is based on cromolyn sodium (the active ingredients of Opticrom). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Gabapentin and Emla - now
- Lamictal and Humira drug interactions for men aged 50-59 - a second ago
- Drug interactions of Ciprofloxacin and Nitrofurantoin - a second ago
- How effective is Ashwanga for Insomnia? - 2 seconds ago
- Could Enbrel cause Muscle Injury? - 3 seconds ago
- Drug interactions of Clindamycin Hydrochloride and Milk Thistle - 5 seconds ago
- High Blood Cholesterol and Infarction - 5 seconds ago
- Could Prednisolone cause Sepsis? - 6 seconds ago
- Could Restoril cause Oesophagitis? - 7 seconds ago
- Fainting and drugs of ingredients of dexamethasone; neomycin sulfate; polymyxin b sulfate - 10 seconds ago